Geneplus IPO

Geneplus locks onto targeted medicine for IPO pitch

After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention   Key Takeaways: The company’s…

Hong Kong’s IPO rally under scrutiny, as ZTE hits new U.S. headwinds

Hong Kong's stock regulator has warned IPO underwriters over the declining qualiy of new listing applications. Is this a red flag for the city's booming IPO market, or just the usual regulatory caution? And the U.S. could fine telecoms equipment maker ZTE $1 billion for bribery in Brazil. Why does Washington think it can force ZTE to pay such a large amount?

BRIEF: China Jinmao disposes of Sanya Ritz-Carlton

Property developer China Jinmao Holdings Group Ltd.  (0817.HK) said  on Tuesday it disposed of its Ritz-Carlton Sanya Yalong Bay on South China’s Hainan Island through an asset securitization deal valuing the resort…